High-resolution mapping of reentrant atrial tachycardias: Relevance of low bipolar voltage.

Atrial flutter Atrial tachycardia Conduction velocity Electroanatomic mapping Reentry Voltage

Journal

Heart rhythm
ISSN: 1556-3871
Titre abrégé: Heart Rhythm
Pays: United States
ID NLM: 101200317

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 18 05 2022
revised: 26 10 2022
accepted: 02 11 2022
pubmed: 12 11 2022
medline: 3 3 2023
entrez: 11 11 2022
Statut: ppublish

Résumé

Bipolar voltage is widely used to characterize the atrial substrate but has been poorly validated, particularly during clinical tachycardias. The purpose of this study was to evaluate the diagnostic performance of voltage thresholds for identifying regions of slow conduction during reentrant atrial tachycardias (ATs). Thirty bipolar voltage and activation maps created during reentrant ATs were analyzed to (1) examine the relationship between voltage amplitude and conduction velocity (CV), (2) measure the diagnostic ability of voltage thresholds to predict CV, and (3) identify determinants of AT circuit dimensions. Voltage amplitude was categorized as "normal" (>0.50 mV), "abnormal" (0.05-0.50 mV), or "scar" (<0.05 mV); slow conduction was defined as <30 cm/s. A total of 266,457 corresponding voltage and CV data points were included for analysis. Voltage and CV were moderately correlated (r = 0.407; P < .001). Bipolar voltage predicted regions of slow conduction with an area under the receiver operating characteristic curve of 0.733 (95% confidence interval 0.731-0.735). A threshold of 0.50 mV had 91% sensitivity and 35% specificity for identifying slow conduction, whereas 0.05 mV had 36% sensitivity and 87% specificity, with an optimal voltage threshold of 0.15 mV. Analyses restricted to the AT circuits identified weaker associations between voltage and CV and an optimal voltage threshold of 0.25 mV. Widely used bipolar voltage amplitude thresholds to define "abnormal" and "scar" tissue in the atria are, respectively, sensitive and specific for identifying regions of slow conduction during reentrant ATs. However, overall, the association of voltage with CV is modest. No clinical predictors of AT circuit dimensions were identified.

Sections du résumé

BACKGROUND BACKGROUND
Bipolar voltage is widely used to characterize the atrial substrate but has been poorly validated, particularly during clinical tachycardias.
OBJECTIVE OBJECTIVE
The purpose of this study was to evaluate the diagnostic performance of voltage thresholds for identifying regions of slow conduction during reentrant atrial tachycardias (ATs).
METHODS METHODS
Thirty bipolar voltage and activation maps created during reentrant ATs were analyzed to (1) examine the relationship between voltage amplitude and conduction velocity (CV), (2) measure the diagnostic ability of voltage thresholds to predict CV, and (3) identify determinants of AT circuit dimensions. Voltage amplitude was categorized as "normal" (>0.50 mV), "abnormal" (0.05-0.50 mV), or "scar" (<0.05 mV); slow conduction was defined as <30 cm/s.
RESULTS RESULTS
A total of 266,457 corresponding voltage and CV data points were included for analysis. Voltage and CV were moderately correlated (r = 0.407; P < .001). Bipolar voltage predicted regions of slow conduction with an area under the receiver operating characteristic curve of 0.733 (95% confidence interval 0.731-0.735). A threshold of 0.50 mV had 91% sensitivity and 35% specificity for identifying slow conduction, whereas 0.05 mV had 36% sensitivity and 87% specificity, with an optimal voltage threshold of 0.15 mV. Analyses restricted to the AT circuits identified weaker associations between voltage and CV and an optimal voltage threshold of 0.25 mV.
CONCLUSION CONCLUSIONS
Widely used bipolar voltage amplitude thresholds to define "abnormal" and "scar" tissue in the atria are, respectively, sensitive and specific for identifying regions of slow conduction during reentrant ATs. However, overall, the association of voltage with CV is modest. No clinical predictors of AT circuit dimensions were identified.

Identifiants

pubmed: 36368515
pii: S1547-5271(22)02590-5
doi: 10.1016/j.hrthm.2022.11.003
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

430-437

Informations de copyright

Copyright © 2022 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Auteurs

F Daniel Ramirez (FD)

Department of Electrophysiology and Cardiac Stimulation, Hôpital Cardiologique du Haut Lévêque, CHU Bordeaux, Bordeaux-Pessac, France; IHU LIRYC (L'Institut de Rythmologie et Modélisation Cardiaque), Bordeaux-Pessac, France; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada. Electronic address: dramirez@ottawaheart.ca.

Marianna Meo (M)

IHU LIRYC (L'Institut de Rythmologie et Modélisation Cardiaque), Bordeaux-Pessac, France.

Corentin Dallet (C)

IHU LIRYC (L'Institut de Rythmologie et Modélisation Cardiaque), Bordeaux-Pessac, France.

Philipp Krisai (P)

Department of Electrophysiology and Cardiac Stimulation, Hôpital Cardiologique du Haut Lévêque, CHU Bordeaux, Bordeaux-Pessac, France; IHU LIRYC (L'Institut de Rythmologie et Modélisation Cardiaque), Bordeaux-Pessac, France.

Konstantinos Vlachos (K)

Department of Electrophysiology and Cardiac Stimulation, Hôpital Cardiologique du Haut Lévêque, CHU Bordeaux, Bordeaux-Pessac, France; IHU LIRYC (L'Institut de Rythmologie et Modélisation Cardiaque), Bordeaux-Pessac, France.

Antonio Frontera (A)

Department of Electrophysiology and Cardiac Stimulation, Hôpital Cardiologique du Haut Lévêque, CHU Bordeaux, Bordeaux-Pessac, France; IHU LIRYC (L'Institut de Rythmologie et Modélisation Cardiaque), Bordeaux-Pessac, France.

Masateru Takigawa (M)

Department of Electrophysiology and Cardiac Stimulation, Hôpital Cardiologique du Haut Lévêque, CHU Bordeaux, Bordeaux-Pessac, France; IHU LIRYC (L'Institut de Rythmologie et Modélisation Cardiaque), Bordeaux-Pessac, France.

Yosuke Nakatani (Y)

Department of Electrophysiology and Cardiac Stimulation, Hôpital Cardiologique du Haut Lévêque, CHU Bordeaux, Bordeaux-Pessac, France; IHU LIRYC (L'Institut de Rythmologie et Modélisation Cardiaque), Bordeaux-Pessac, France.

Takashi Nakashima (T)

Department of Electrophysiology and Cardiac Stimulation, Hôpital Cardiologique du Haut Lévêque, CHU Bordeaux, Bordeaux-Pessac, France; IHU LIRYC (L'Institut de Rythmologie et Modélisation Cardiaque), Bordeaux-Pessac, France.

Clémentine André (C)

Department of Electrophysiology and Cardiac Stimulation, Hôpital Cardiologique du Haut Lévêque, CHU Bordeaux, Bordeaux-Pessac, France; IHU LIRYC (L'Institut de Rythmologie et Modélisation Cardiaque), Bordeaux-Pessac, France.

Tsukasa Kamakura (T)

Department of Electrophysiology and Cardiac Stimulation, Hôpital Cardiologique du Haut Lévêque, CHU Bordeaux, Bordeaux-Pessac, France; IHU LIRYC (L'Institut de Rythmologie et Modélisation Cardiaque), Bordeaux-Pessac, France.

Takamitsu Takagi (T)

Department of Electrophysiology and Cardiac Stimulation, Hôpital Cardiologique du Haut Lévêque, CHU Bordeaux, Bordeaux-Pessac, France; IHU LIRYC (L'Institut de Rythmologie et Modélisation Cardiaque), Bordeaux-Pessac, France.

Aline Carapezzi (A)

Boston Scientific, Bordeaux, Aquitaine, France.

Romain Tixier (R)

Department of Electrophysiology and Cardiac Stimulation, Hôpital Cardiologique du Haut Lévêque, CHU Bordeaux, Bordeaux-Pessac, France; IHU LIRYC (L'Institut de Rythmologie et Modélisation Cardiaque), Bordeaux-Pessac, France.

Rémi Chauvel (R)

Department of Electrophysiology and Cardiac Stimulation, Hôpital Cardiologique du Haut Lévêque, CHU Bordeaux, Bordeaux-Pessac, France; IHU LIRYC (L'Institut de Rythmologie et Modélisation Cardiaque), Bordeaux-Pessac, France.

Ghassen Cheniti (G)

Department of Electrophysiology and Cardiac Stimulation, Hôpital Cardiologique du Haut Lévêque, CHU Bordeaux, Bordeaux-Pessac, France; IHU LIRYC (L'Institut de Rythmologie et Modélisation Cardiaque), Bordeaux-Pessac, France.

Josselin Duchateau (J)

Department of Electrophysiology and Cardiac Stimulation, Hôpital Cardiologique du Haut Lévêque, CHU Bordeaux, Bordeaux-Pessac, France; IHU LIRYC (L'Institut de Rythmologie et Modélisation Cardiaque), Bordeaux-Pessac, France.

Thomas Pambrun (T)

Department of Electrophysiology and Cardiac Stimulation, Hôpital Cardiologique du Haut Lévêque, CHU Bordeaux, Bordeaux-Pessac, France; IHU LIRYC (L'Institut de Rythmologie et Modélisation Cardiaque), Bordeaux-Pessac, France.

Frédéric Sacher (F)

Department of Electrophysiology and Cardiac Stimulation, Hôpital Cardiologique du Haut Lévêque, CHU Bordeaux, Bordeaux-Pessac, France; IHU LIRYC (L'Institut de Rythmologie et Modélisation Cardiaque), Bordeaux-Pessac, France.

Mélèze Hocini (M)

Department of Electrophysiology and Cardiac Stimulation, Hôpital Cardiologique du Haut Lévêque, CHU Bordeaux, Bordeaux-Pessac, France; IHU LIRYC (L'Institut de Rythmologie et Modélisation Cardiaque), Bordeaux-Pessac, France.

Michel Haïssaguerre (M)

Department of Electrophysiology and Cardiac Stimulation, Hôpital Cardiologique du Haut Lévêque, CHU Bordeaux, Bordeaux-Pessac, France; IHU LIRYC (L'Institut de Rythmologie et Modélisation Cardiaque), Bordeaux-Pessac, France.

Pierre Jaïs (P)

Department of Electrophysiology and Cardiac Stimulation, Hôpital Cardiologique du Haut Lévêque, CHU Bordeaux, Bordeaux-Pessac, France; IHU LIRYC (L'Institut de Rythmologie et Modélisation Cardiaque), Bordeaux-Pessac, France.

Rémi Dubois (R)

IHU LIRYC (L'Institut de Rythmologie et Modélisation Cardiaque), Bordeaux-Pessac, France.

Nicolas Derval (N)

Department of Electrophysiology and Cardiac Stimulation, Hôpital Cardiologique du Haut Lévêque, CHU Bordeaux, Bordeaux-Pessac, France; IHU LIRYC (L'Institut de Rythmologie et Modélisation Cardiaque), Bordeaux-Pessac, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH